Xingwang Zhang

CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Clinical Cancer Research · 2021 · 263 citations · Full text

Biotinylated liposomes as potential carriers for the oral delivery of insulin

Xingwang Zhang, Jianping Qi, Yi Lü et al. · Nanomedicine Nanotechnology Biology and Medicine · 2013 · 193 citations

Nanomedicine, Engineering, Diabetes +6

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Cell Research · 2022 · 178 citations · Full text

Cell Therapy, Medicine, Immunology +8

Selenium-layered nanoparticles serving for oral delivery of phytomedicines with hypoglycemic activity to synergistically potentiate the antidiabetic effect

Wenji Deng, Huan Wang, Baojian Wu et al. · Acta Pharmaceutica Sinica B · 2018 · 95 citations · Full text

Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique

Xingwang Zhang, Ningyun Sun, Baojian Wu et al. · Powder Technology · 2007 · 92 citations

Materials Science, Engineering, Polymer Science +5